Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A novel FBW7/NFAT1 axis regulates cancer immunity in sunitinib-resistant renal cancer by inducing PD-L1 expression
Wentao Liu, Dianyun Ren, Wei Xiong, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches
Fangfang Liu, Jingyu Chen, Kai Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 47
Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers : the “all-around warrior” in immunotherapy
Qiang Liu, Yujing Guan, Shenglong Li
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 17
ZDHHC2-mediated AGK palmitoylation activates AKT/mTOR signaling to reduce sunitinib sensitivity in renal cell carcinoma
Yan Sun, Liang Zhu, Pian Liu, et al.
Cancer Research (2023) Vol. 83, Iss. 12, pp. 2034-2051
Open Access | Times Cited: 30
FBXW7 in breast cancer: mechanism of action and therapeutic potential
Siyu Chen, Ping Leng, Jinlin Guo, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 17
The potential value of cuprotosis (copper-induced cell death) in the therapy of clear cell renal cell carcinoma
Xiaochen Qi
American Journal of Cancer Research (2022) Vol. 12, Iss. 8, pp. 3947-3966
Open Access | Times Cited: 24
Molecular insights and clinical implications for the tumor suppressor role of SCFFBXW7 E3 ubiquitin ligase
Yihang Qi, Abdol-Hossein Rezaeian, Jingchao Wang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189140-189140
Closed Access | Times Cited: 5
The role of histone methylase and demethylase in antitumor immunity: A new direction for immunotherapy
Yuanling Zhang, Junhao Chen, Hang Liu, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 10
NFAT signaling dysregulation in cancer: Emerging roles in cancer stem cells
Yibin Lin, Yifu Song, Yaochuan Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115167-115167
Open Access | Times Cited: 10
Unlocking the therapeutic potential of the NFAT pathway in kidney diseases
Somya Shreya, Neha Dagar, Anil Bhanudas Gaikwad
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
LRRK2 reduces the sensitivity to TKI and PD-1 blockade in ccRCC via activating LPCAT1
Yulong Hong, Weidong Li, Zhuo Xing, et al.
Oncogene (2025)
Closed Access
Circulating bile acid profiles characteristics and the potential predictive role in clear cell renal cell carcinoma progression
Qichao Wang, Jingyi Cao, Guangyue Wang, et al.
BMC Nephrology (2025) Vol. 26, Iss. 1
Open Access
Identification of immunogenic cell death-related signature on prognosis and immunotherapy in kidney renal clear cell carcinoma
Silin Jiang, Yuxiang Dong, Jun Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
FBXW7 attenuates tumor drug resistance and enhances the efficacy of immunotherapy
Shimin Chen, Jichun Lin, Jiaojiao Zhao, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 8
Mechanisms of sunitinib resistance in renal cell carcinoma and associated opportunities for therapeutics
Yunxia Wang, Xiaolin Liu, Luyao Gong, et al.
British Journal of Pharmacology (2023) Vol. 180, Iss. 23, pp. 2937-2955
Closed Access | Times Cited: 8
FBXW7 and human tumors: mechanisms of drug resistance and potential therapeutic strategies
Wanqing Wang, Kaipeng Jiang, Xue Liu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 7
The E3 ligase RBCK1 reduces the sensitivity of ccRCC to sunitinib through the ANKRD35-MITD1-ANXA1 axis
Yapeng Wang, Mou Peng, Yawen Zhong, et al.
Oncogene (2023) Vol. 42, Iss. 13, pp. 952-966
Closed Access | Times Cited: 7
Recent Insight on Regulations of FBXW7 and Its Role in Immunotherapy
L. Xing, Leidi Xu, Yong Zhang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 10
A comprehensive analysis of the FOX family for predicting kidney renal clear cell carcinoma prognosis and the oncogenic role of FOXG1
Wenjie Yang, Hualin Chen, Lin Ma, et al.
Aging (2022) Vol. 14, Iss. 24, pp. 10107-10124
Open Access | Times Cited: 9
RNF26 up-regulates PD-L1 to regulate the cancer immune response in ccRCC
Weigang Ren, Jing Li, R Zeng, et al.
Biocell (2024) Vol. 48, Iss. 9, pp. 1323-1330
Open Access | Times Cited: 1
Disulfidptosis-associated LncRNA signature predicts prognosis and immune response in kidney renal clear cell carcinoma
Kangjie Xu, Dongling Li, Kangkang Ji, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
ORAI2 is Important for the Development of Early-Stage Post-Irradiation Fibrosis in Salivary Glands
Honglin Li, Yubin Cao, Guile Zhao, et al.
International Journal of Radiation Oncology*Biology*Physics (2024)
Closed Access | Times Cited: 1
The antihypertensive felodipine shows synergistic activity with immune checkpoint blockade and inhibits tumor growth via NFAT1 in LUSC
Siyu Liang, Hongkai Xiao
Open Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 2
Construction of five disulfidptosis-related lncRNA signature for predicting prognosis and immune activity in kidney renal clear cell carcinoma
Kangjie Xu, Dongling Li, Minglei Zhang, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Bioinformatics and in vitro-based comprehensive analysis of EVI2A expression and its immunological and prognostic significance in Kidney Renal Clear Cell Carcinoma
Sheng Li, Fucun Zheng, Situ Xiong, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Construction of a five-disulfidptosis-related-lncRNA signature for predicting prognosis and immune activity in kidney renal clear cell carcinoma
Kangjie Xu, Dongling Li, Hui Liu, et al.
Research Square (Research Square) (2024)
Open Access
Page 1 - Next Page

Scroll to top